NCT00977301 Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA) Status COMPLETED Phase PHASE1
NCT00932529 Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting Status COMPLETED Phase PHASE4
NCT00910988 Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone Status COMPLETED Phase NA
NCT00895921 Examining the Effects of Antipsychotic Medications on Insulin Sensitivity Status COMPLETED Phase PHASE4
NCT00885690 Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA) Status TERMINATED Phase NA
NCT00876772 Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2/PHASE3
NCT00845026 A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients Status COMPLETED Phase PHASE2
NCT00802100 Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia Status COMPLETED Phase PHASE4
NCT00759460 Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00759421 Exploratory Cognition Study of Sertindole in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00737191 Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain Status WITHDRAWN Phase NA
NCT00728195 An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia Status COMPLETED Phase PHASE2
NCT00712686 Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia Status COMPLETED Phase PHASE3